Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. In a new study, a research group describes their development of a new antibody design that increases brain uptake of antibodies almost 100-fold.